How do I select a fractional CRO for a PE-backed portfolio company in 2027?

The job this role is actually hired to do

A fractional CRO in a PE-backed portfolio company is not a part-time version of a full-time CRO. The role exists because the sponsor bought a revenue thesis — usually written into the investment committee memo before close — and the company's existing commercial leadership cannot execute it at the speed the hold period demands. Understanding that distinction is the entire selection problem. If you hire against the wrong job description, you will interview well-credentialed people who are wrong for the mandate.

There are four distinct mandates that get labeled "fractional CRO," and they demand different people:

The diagnostic mandate. The sponsor closed the deal, the founder-CEO is still running sales, and nobody has a defensible view of why the pipeline converts the way it does. The engagement is 3–6 months, heavy on data forensics, and the deliverable is a segmentation, a coverage model, a quota-capacity build, and an honest read on whether the existing VP of Sales can be promoted or must be replaced. This person needs analytical depth and the political spine to write "your VP Sales cannot scale past $15M" in a document the CEO will read. They do not need to be a great closer.

The interim mandate. The CRO left — resigned, was pushed, or never existed — and someone has to own the number while a retained search runs. This is 4–9 months, 3–4 days a week, and the job is stabilization: keep reps from quitting, protect forecast credibility with the board, and hand a functioning machine to the permanent hire. This person needs operating reps, not consulting reps. Ask specifically whether they have carried a number, not just advised on one.

The build mandate. The company has product-market fit in one segment and the thesis requires a second motion — enterprise on top of mid-market, channel on top of direct, a new geography, a cross-sell into the platform's other add-ons. This is 9–18 months at 2 days a week, and the deliverable is a repeatable motion with named owners. This is the mandate where genuine domain adjacency matters most: someone who has built enterprise selling in vertical SaaS is not automatically the right person to build a channel in industrial services.

The integration mandate. The platform has acquired two or three add-ons and the combined commercial organization is a mess of overlapping territories, three CRMs, incompatible comp plans, and account teams calling the same buyer. This is the most underrated fractional mandate and the one where the wrong hire costs the most. Ask directly about post-merger commercial integration experience — territory harmonization, comp plan transition mechanics, CRM consolidation sequencing — because it is a genuinely different skill from growth leadership.

Write down which of the four you are hiring before you take a single call. The most common selection failure in the portfolio-company context is that the CEO wants the interim mandate, the sponsor wants the diagnostic mandate, and the person hired is a build-mandate operator who is bored by both. Six months later everyone is unhappy and nobody can articulate why.

One more piece of the job definition that PE-backed companies get wrong: the fractional CRO's real client is ambiguous. They report to the CEO, but the operating partner introduced them, and the board sees their materials. Decide before you sign who conducts the check-ins, who can extend or terminate the engagement, and whether the CRO is expected to give the sponsor an unfiltered read on the CEO. If you leave that ambiguous, you have created a spy, and the CEO will figure it out within a quarter and route around them.

How the role fits the RevOps stack

The fractional CRO does not replace your RevOps function — they either build one, unblock one, or expose that the one you have is doing reporting instead of operating. Getting this interface right is a selection criterion, not an onboarding detail, because a CRO who cannot work through a RevOps team will insist on rebuilding it around themselves and leave you worse off at exit.

The practical question to ask in an interview: "Walk me through the first four artifacts you would ask my RevOps team to produce, and what you would do if they cannot produce them." Strong answers converge on a similar list — a clean bookings-to-revenue bridge, a stage-by-stage conversion table with aging, a rep-level attainment distribution, and a data-quality read on the CRM's opportunity object. Weak answers describe dashboards they would build themselves.

The stack interface breaks down in three predictable places, and each one gives you an interview question.

The system of record is not trusted. In most lower-middle-market portfolio companies, the CRM has been in place three to seven years, has been through at least one admin turnover, and contains stage definitions nobody enforces. A fractional CRO who says "first we migrate off HubSpot onto Salesforce" in month one is solving a tooling problem to avoid a discipline problem. The better answer is a 30-day hygiene sprint — enforce stage exit criteria, close out the zombie pipeline older than two sales cycles, and get close dates to mean something — before touching the platform decision. Ask what they would do if 40% of open pipeline had a close date in the past. The answer tells you whether they have actually operated in a messy portfolio company.

RevOps reports to the wrong place. If RevOps sits under Finance, it will produce accurate reporting and no operating leverage. If it sits under Marketing, it will produce attribution models and no forecast discipline. A fractional CRO with real portfolio experience will have a point of view on where RevOps should sit during the hold period and will be able to defend it against the CFO, who often owns the function by default. Ask them how they have handled the CFO relationship when the two disagreed on forecast methodology.

There is no RevOps function at all. Below roughly $10M ARR this is common — there is a Salesforce admin who is really an ops generalist, and a marketing person who runs the automation platform. Here the fractional CRO's job includes writing the RevOps job description and making the case for the first dedicated hire. Ask candidates what they would do with the first RevOps headcount at your revenue scale, and whether they would hire an analyst or a systems person first. There is no universally right answer, but the reasoning reveals a lot.

The exit consideration matters here too. A buyer's commercial diligence will interrogate your data room: cohort retention, net revenue retention, pipeline coverage history, quota attainment distribution, churn reasons coded consistently. That data has to have been captured correctly for years, not reconstructed in the eight weeks before a process. A fractional CRO who has been through a sell-side process knows which artifacts diligence will demand and will instrument for them early. Ask directly: "What did the buyer's team ask for that you wish you had started tracking two years earlier?" Candidates who have actually lived through an exit answer this fluently and specifically. Candidates who have not will give you a generic answer about clean data.

Pricing, engagement models, and typical ranges

Fractional CRO pricing is opaque, quoted inconsistently, and frequently the reason a good engagement ends badly. There are four structures in common use, and you should understand all four before the first pricing conversation, because the structure matters more than the rate.

Monthly retainer for defined days. The most common model. You buy a fixed number of days or a fixed day-per-week commitment for a monthly fee. Rates in the North American market for genuinely experienced operators — people who have run a revenue organization through a scale change, not just carried a bag — typically land in a range where one day a week costs meaningfully less than a quarter of a full-time CRO's fully loaded cost, but two to three days a week starts approaching it. Do the arithmetic explicitly before you negotiate: take the fully loaded cost of the full-time CRO you would otherwise hire, including equity value at your expected exit multiple, divide by the days you would get from them, and compare per-day. Fractional should be cheaper per outcome, not necessarily cheaper per day — you are paying a premium rate for a seniority level you could not otherwise afford, and the savings come from buying less of it.

Project or milestone fee. Better for the diagnostic mandate. You define deliverables — segmentation study, coverage model, comp plan redesign, sales process documentation, hiring scorecards for three roles — and pay against completion. The advantage is that scope is legible and you cannot drift into paying a retainer for someone who has stopped producing. The disadvantage is that it invites a consulting posture, and it discourages the CRO from doing the unglamorous operating work — running the forecast call, coaching a struggling rep — that is often where the value actually is.

Retainer plus performance. A reduced monthly fee plus a bonus tied to specific outcomes. This is where most PE-backed engagements want to go and where most of them get the design wrong. The failure mode is tying the bonus to bookings in a period shorter than the sales cycle. If your average cycle is 5 months and the engagement is 6 months, a bookings-linked bonus rewards deals that were already in flight at signing. Tie it instead to leading indicators the CRO genuinely controls — qualified pipeline created, coverage ratio achieved, a hired-and-ramped sales leader, forecast accuracy within a stated band for three consecutive months. Define measurement in the contract, including who computes the number and what happens if the CRM data is disputed.

Equity or options. Increasingly requested, rarely appropriate for short engagements, sometimes the right answer for a 12–18 month build mandate. Two cautions specific to the PE context. First, the sponsor's management incentive plan has a defined pool, and carving a fractional executive into it requires sponsor approval and dilutes the management team you actually need to retain through exit — this is a governance conversation, not a negotiation the CEO can conclude alone. Second, options with a standard four-year vest are meaningless to someone engaged for twelve months; if you go this route, use a shorter vest tied to the engagement term or a phantom equity instrument that pays on a liquidity event. Get the sponsor's counsel involved early; retrofitting this after a handshake is expensive and sours the relationship.

Beyond the headline rate, three cost lines get missed and cause friction:

• Expenses and travel. A fractional CRO who needs to be on-site with a distributed sales team two days a month has real travel cost. Agree a cap and whether travel days count against contracted days. This is the single most common billing dispute.
• Ramp inefficiency. Weeks one through four are diagnostic. You are paying full rate for output you will not see for a month. Budget for it rather than being surprised, and structure the first month around a defined diagnostic deliverable so the time is at least legible.
• Overlap with the permanent hire. If the mandate ends with a full-time CRO, plan a 30–60 day overlap. Paying two CROs briefly is far cheaper than a cold handoff that resets the organization.

On term structure: start with a 90-day initial period with a defined diagnostic output, then a longer extension. Both sides get an honest off-ramp, and the diagnostic gives you a real work sample rather than a reference call. Include a 30-day termination clause with no penalty after the initial period. If a candidate resists a 90-day start, that is information — it usually means they have been burned by clients who use short engagements to extract a free strategy document, which is a fair concern, so meet them by paying a fair diagnostic fee rather than by committing to twelve months sight-unseen.

Watch for two structural conflicts specific to fractional executives. First, concurrent clients: ask how many engagements they are running and whether any are competitive with you. Three concurrent two-day-a-week engagements is not arithmetically possible without someone getting shortchanged. Second, the placement conflict: a fractional CRO whose firm also does executive search has an incentive to conclude that you need a full-time CRO they can place. Disclose and price that conflict rather than pretending it does not exist.

How to evaluate and shortlist candidates

Run this as a structured process with scored criteria, not as a series of coffee chats that end in a gut call. The talent market for fractional executives is full of people who present extremely well — they have spent careers selling — and interview performance correlates weakly with operating outcomes. Structure is your defense.

Build the scorecard from the value creation plan, not from a generic job description. Pull the specific commercial assumptions out of the sponsor's model: the ARR trajectory, the assumed net revenue retention, the gross margin path, the sales-efficiency ratio implied by the headcount plan. Turn each into a capability the CRO must have demonstrated. If the model assumes NRR moves from 98% to 112%, you need someone who has actually moved expansion revenue, which is a different skill set from new logo acquisition. If it assumes headcount doubles, you need someone who has hired and ramped at that rate and can tell you their historical ramp curve and rep failure rate.

Screen for stage match harder than for industry match. The most reliable predictor of fit is whether the candidate has operated at your revenue band and through the specific transition ahead of you. Someone who took a company from $8M to $25M has a directly transferable playbook for a company at $10M. Someone who ran a $400M revenue org at a public company has managed a machine, not built one, and often struggles with the resource constraints of a portfolio company at a fifth the size. Industry adjacency matters, but it is second-order; a strong operator learns your buyer in six weeks, whereas nobody learns "how to build a first sales team" in six weeks.

Insist on PE-specific experience, and probe what it actually was. "I have worked with PE-backed companies" can mean anything. Ask which sponsors, which fund sizes, whether the company was a platform or an add-on, what the hold period was, whether they made it to exit, and what the outcome was. Ask what the operating partner asked them for monthly and what the board pack contained. Someone with real portfolio experience describes the reporting cadence, the QBR format, and the 100-day plan structure without prompting. Someone without it talks about strategy in the abstract.

Use a work-sample exercise, and pay for it. Give the top two or three candidates anonymized data — 18 months of opportunity records, rep attainment, and your current forecast — and ask for a two-page read plus a 45-minute walkthrough. Pay them for the time; you will get better work and you will not be the client who extracts free consulting. Watch for whether they ask clarifying questions before diving in, whether they find the data problems you already know about, and whether they say something uncomfortable. A candidate who returns a tidy deck that flatters your existing plan is telling you how they will behave when the number is missed.

Reference specifically, and go around the list. Ask every reference the same four questions: what did they change, what did they leave unfinished, how did they handle the moment they disagreed with the CEO, and would you hire them again for a different mandate. Then find one reference they did not give you — a former direct report, a RevOps lead, a CFO from a prior engagement. Reports and finance leaders see fractional executives differently from CEOs, and the gap between those views is where the useful signal lives.

Structure the interview loop deliberately. A workable sequence: a 45-minute CEO screen on mandate fit; a 60-minute deep dive with the operating partner on the value creation plan; a 60-minute working session with the RevOps and finance leads on data and forecast mechanics; the paid work sample and walkthrough; then references. Involve the existing sales leadership somewhere in the loop even when the mandate might end in their replacement — you will learn from how the candidate handles that conversation, and if the sales leader is staying, they need to have met the person who will be directing them.

Concrete disqualifiers worth holding firm on: cannot name a specific number they owned and whether they hit it; describes every prior engagement as a success; will not commit to a written 90-day plan; will not disclose concurrent client count; wants a twelve-month commitment with no early termination; frames the first deliverable as a tooling migration; cannot explain how they would work with a RevOps team rather than around one; has never fired anyone.

Two more things to verify before you sign. Check availability honestly — ask which days, which hours, and what happens when your board meeting collides with another client's. Ask about the exit plan from day one: what does the organization look like when they leave, who owns each thing they built, and what is the trigger to start the permanent search. A fractional CRO without a defined end state becomes a permanent expense with none of the accountability of a permanent hire.

A decision framework you can actually run

Sequence the decision so you commit money in proportion to what you know. The framework below moves from cheapest decisions to most expensive, and each gate has a clean exit.

Gate one: confirm it is a leadership gap. Fractional CROs get hired to fix problems that are not leadership problems. If pipeline is thin because marketing spend was cut, if win rates dropped because a competitor repriced, if churn spiked because of a product regression — a fractional CRO will diagnose those correctly and then be unable to fix them, and you will have spent six months and a meaningful fee learning something the RevOps team could have told you. The honest test: write down the three things you expect to change, and ask whether each requires an executive's authority or an operator's hours. If the answer is hours, hire hours.

Gate two: name the mandate and get the CEO and sponsor to sign the same sentence. Literally one sentence: "In the next N months this person will do X, measured by Y." If the CEO and the operating partner write different sentences, stop and resolve it before you interview anyone. This is the highest-leverage 30 minutes in the entire process.

Gate three: score against the plan-derived scorecard. Weight stage match and mandate-specific experience heaviest. Resist the pull toward the most impressive logo — brand-name experience at a scale far above yours is frequently a negative signal in a portfolio company that needs someone to build a territory model in a spreadsheet.

Gate four: paid work sample. Treated seriously, this replaces roughly half your interview process. What you are buying is a look at how they think when the data is ugly.

Gate five: references, including one you sourced yourself. Weight the off-list reference more heavily than the provided ones.

Gate six: 90-day engagement with a written plan. The plan should name deliverables by week, the metrics they will own, the decision rights they hold, and the reporting cadence to both CEO and sponsor. Vague plans produce vague accountability.

Gate seven: extension decision on evidence. At day 75, review against the written plan. Extend, restructure, or exit. Have this conversation on the calendar from the start so it does not feel like an ambush.

Two governance items to settle before day one. First, decision rights: can this person terminate a rep, change a comp plan, reassign a territory, or sign a tool contract — and to what dollar threshold? Fractional executives with responsibility and no authority produce recommendations, not results. Second, communication protocol with the sponsor: how often, in what format, and does the CEO see it first? The cleanest arrangement is that everything the CRO sends the sponsor, the CEO sees simultaneously — which preserves trust while giving the board its visibility.

Finally, plan the handoff before it is needed. The endgame for most of these engagements is a permanent CRO or a promoted internal leader. Define the trigger — a revenue threshold, a completed milestone, a date — and start the search 90 days ahead of it. The fractional CRO should help write the scorecard for their own successor and participate in the interview loop. That is a fair test of whether you hired someone building an organization or someone building a dependency.

Related questions

When should a portfolio company hire a full-time CRO instead?

When the mandate is indefinite, when the revenue organization exceeds roughly 25–30 quota-carrying people, or when the role requires daily presence in deals and coaching. Fractional works for defined transitions; permanent works for ongoing operation at scale.

Who should the fractional CRO report to?

The CEO, with a defined reporting line to the board or operating partner for metrics. Dual accountability without a clear primary reporting line creates a political problem the CEO will eventually resolve by isolating the CRO.

How do I measure whether the engagement is working at 90 days?

Against the written 90-day plan, not against bookings. Look for forecast accuracy improvement, a defensible coverage model, clarity on the sales team's talent picture, and whether the CEO now has better questions than they had at day one.

Can one fractional CRO cover multiple portfolio companies?

Sponsors sometimes try this and it usually underperforms. Each company needs enough presence to build credibility with its own sales team. A shared resource across three companies delivers advisory value, not operating leverage.

What if the existing VP of Sales resents the hire?

Expect it and manage it explicitly. Announce the mandate and its end date internally, define decision rights in writing, and have the CEO — not the fractional CRO — deliver the framing. Most friction comes from ambiguity, not from ego.

FAQ

How many days per week does a fractional CRO actually need to be effective?

It depends on the mandate. A diagnostic mandate can work at one to two days a week because the output is analysis. An interim mandate needs three to four days because someone must run the forecast call, sit in escalated deals, and be reachable when a rep quits. A build mandate typically works at two days a week once the diagnostic phase ends. Below one day a week you are buying advice, not leadership, and you should price and label it that way.

Should the sponsor or the CEO select the fractional CRO?

The CEO should make the final call, with the sponsor holding a veto and running the sourcing. Operating partners have far better networks for this role and should introduce candidates. But a CRO the CEO did not choose starts with a credibility problem inside the company that is very hard to recover from. If the sponsor has so little confidence in the CEO's judgment that they must impose the choice, the real issue is the CEO, and hiring a fractional CRO around them will not fix it.

How do I handle a candidate who wants equity in the portfolio company?

Treat it as a sponsor governance question, not a compensation negotiation. The management incentive plan has a fixed pool and every share allocated to a fractional executive is a share unavailable to the team you need through exit. If the engagement is long enough to justify it — twelve months or more on a build mandate — discuss phantom equity or a transaction bonus tied to a liquidity event rather than standard options with a four-year vest that will never mature within the engagement.

What does a good 90-day plan from a fractional CRO look like?

Weeks one to four: data and pipeline diagnostic, rep-by-rep talent assessment, CRM hygiene read, and interviews with the top ten customers and the last ten losses. Weeks five to eight: segmentation and coverage recommendation, forecast methodology reset, and a specific talent recommendation on the existing leadership. Weeks nine to twelve: comp and quota plan for the next fiscal period, hiring scorecards, and a written handoff structure. It should name the metrics they will own and the decisions they can make alone.

Is a fractional CRO a red flag to a future buyer during diligence?

Not by itself, and often the opposite — buyers read a deliberate fractional engagement as capital discipline. What draws scrutiny is a revenue organization that depends on someone who is leaving. Diligence will ask who owns the forecast, who owns the comp plan, and whether the commercial playbook is documented or lives in one contractor's head. Instrument the handoff so the answer is institutional, and the fractional history becomes a non-issue.

What is the single most common reason these engagements fail?

Undefined decision rights. The CRO is accountable for revenue but cannot change a comp plan, remove an underperformer, or reallocate territory without a CEO approval that keeps getting deferred. They produce increasingly good recommendations that nobody acts on, the number gets missed anyway, and the engagement ends with both sides feeling misled. Settle authority thresholds in writing before day one.

Sources

• https://hbr.org/2019/01/how-private-equity-firms-hire-ceos — Harvard Business Review on PE hiring practices for portfolio executives
• https://www.bain.com/insights/topics/global-private-equity-report/ — Bain & Company Global Private Equity Report, annual data on hold periods and value creation
• https://www.mckinsey.com/industries/private-capital/our-insights — McKinsey research on private capital and portfolio operating models
• https://www.bcg.com/publications/2023/creating-value-in-private-equity — BCG on value creation levers in private equity
• https://www.sec.gov/education/capitalraising/building-blocks/private-equity — SEC investor education on private equity structures
• https://www.nvca.org/ — National Venture Capital Association, model legal documents and equity practices
• https://www.investopedia.com/terms/f/fractional-executive.asp — Investopedia reference on fractional executive engagement models
• https://sloanreview.mit.edu/topic/leadership/ — MIT Sloan Management Review leadership research

Related on PULSE

• How do I structure a 90-day plan for a new revenue leader?
• What does a RevOps function look like at a $10M ARR company?
• How do I design a sales comp plan during a PE hold period?
• What does commercial diligence look for in a sell-side process?
• When should we hire our first dedicated RevOps analyst?
• How do I consolidate CRMs after a bolt-on acquisition?